Infectious diseases are a leading cause of illness and death worldwide, and are particularly dangerous to individuals with compromised immune systems. Immunocompromised people are less apt to control primary infection, more susceptible to developing complications from infections, and often afflicted by pathogens that rarely cause disease in the general population. The Infectious Disease Sciences Program at Fred Hutch seeks to improve detection, prevention, and treatment outcomes for infectious diseases, through targeted laboratory research and multi-site clinical trials.
Our mission is to advance knowledge of host-pathogen interactions and develop innovative management strategies for infectious diseases in immunocompromised and immunocompetent persons.
Situated within the Vaccine and Infectious Disease Division, our program has four pillars of focus and expertise: research, patient care, training and multidisciplinary events designed to share innovations and best practices, both locally and around the world. Established in the 1980s at Fred Hutch, the Infectious Disease Sciences (IDS) Program has been home to many major, innovative programs, including projects to study herpesvirus infections (with an emphasis on CMV, HSV, HHV-6, and HHV-8), respiratory viruses, invasive fungal disease, the microbiome and its role in human disease, HIV cure, infection-related cancers, and infection control and hospital epidemiology.
Our researchers conduct interdisciplinary, collaborative research and training at the highest level of excellence. Our Program has strong and long-standing collaborations and partnerships with multiple stakeholders, including patients and researchers, physicians and medical centers, data scientists and policy makers, industry sponsors, and federal agencies. The IDS faculty have a wide range of expertise and diverse clinical and research backgrounds, and many have joint appointments with the University of Washington School of Medicine and the Seattle Cancer Care Alliance, where they contribute to teaching, training, patient care and research missions.
Our physicians and scientists apply their extensive experience in immunocompetent and immunocompromised populations to study the epidemiology of infectious diseases, investigate emerging infectious diseases, develop novel diagnostic methods and perform clinical trials for new treatments for major infections. Specific areas of research focus include:
IDS houses major initiatives aimed at expediting research progress and improving clinical outcomes by fostering collaborations within the Hutch and around the world, while supporting our team-oriented approach to patient care. Through these initiatives, we seek to advance our understanding of infectious diseases, and to improve prevention and treatment of these diseases.
Director, Program Operations
Limei Fan oversees the diverse functions of IDS operations, including financial planning, grant and contract activities, personnel management, protocol management and regulatory compliance, faculty communication and administration, and scientific symposia, conferences and events.
She leads efforts to develop and implement program procedures, mentors staff, serves as senior project manager in major studies and manages affiliate relationships. Trained in executive leadership, and with a management background in private-public-education-business partnerships, Limei focuses on practical approaches to advance learning, optimize resources and provide excellent service.